SciClone Pharmaceuticals Inc is a Delaware corporation was incorporated in 1990. The Company is a specialty pharmaceutical company with a substantial commercial business and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders. The Company operates is two segments based on the nature and locations of its customers: China and the rest of the world which includes its U.S and Hong Kong operations. Its competitors include pharmaceutical companies, biotechnology firms, universities and other research institutions, in the U.S,China and other territories, that are actively engaged in research and development or marketing of products in the therapeutic areas the Company is pursuing. The Company's products in clinical development in the U.S, China and other foreign countries are subject to approval by the FDA, the CFDA and similar regulatory authorities.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.